BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30248063)

  • 1. PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.
    Bottero V; Santiago JA; Potashkin JA
    J Parkinsons Dis; 2018; 8(4):529-537. PubMed ID: 30248063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A network approach to diagnostic biomarkers in progressive supranuclear palsy.
    Santiago JA; Potashkin JA
    Mov Disord; 2014 Apr; 29(4):550-5. PubMed ID: 24347522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson's Disease: A machine learning study.
    Bianco MG; Cristiani CM; Scaramuzzino L; Sarica A; Augimeri A; Chimento I; Buonocore J; Parrotta EI; Quattrone A; Cuda G; Quattrone A
    Parkinsonism Relat Disord; 2024 Jun; 123():106978. PubMed ID: 38678852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
    Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
    Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
    Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale.
    Cubo E; Stebbins GT; Golbe LI; Nieves A; Leurgans S; Goetz CG; Kompoliti K
    Mov Disord; 2000 Mar; 15(2):276-9. PubMed ID: 10752576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of a new MRI for visualizing cerebellar involvement in progressive supranuclear palsy.
    Hara K; Watanabe H; Ito M; Tsuboi T; Watanabe H; Nakamura R; Senda J; Atsuta N; Adachi H; Aiba I; Naganawa S; Sobue G
    Parkinsonism Relat Disord; 2014 Feb; 20(2):157-61. PubMed ID: 24172606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.
    Quattrone A; Morelli M; Vescio B; Nigro S; Le Piane E; Sabatini U; Caracciolo M; Vescio V; Quattrone A; Barbagallo G; Stanà C; Nicoletti G; Arabia G; Nisticò R; Novellino F; Salsone M
    Mov Disord; 2019 Apr; 34(4):487-495. PubMed ID: 30759325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.
    Doty RL; Golbe LI; McKeown DA; Stern MB; Lehrach CM; Crawford D
    Neurology; 1993 May; 43(5):962-5. PubMed ID: 8492953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program.
    Santiago JA; Bottero V; Potashkin JA
    Front Aging Neurosci; 2018; 10():157. PubMed ID: 29896099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy.
    Ghourchian S; Mousavi A; Zamani B; Shahidi G; Rohani M
    Clin Neurol Neurosurg; 2019 Aug; 183():105383. PubMed ID: 31181432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
    Ondo W; Warrior D; Overby A; Calmes J; Hendersen N; Olson S; Jankovic J
    Arch Neurol; 2000 Oct; 57(10):1464-9. PubMed ID: 11030799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote at-home wearable-based gait assessments in Progressive Supranuclear Palsy compared to Parkinson's Disease.
    Sharma M; Mishra RK; Hall AJ; Casado J; Cole R; Nunes AS; Barchard G; Vaziri A; Pantelyat A; Wills AM
    BMC Neurol; 2023 Dec; 23(1):434. PubMed ID: 38082255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning.
    De Vos M; Prince J; Buchanan T; FitzGerald JJ; Antoniades CA
    Gait Posture; 2020 Mar; 77():257-263. PubMed ID: 32078894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.